News Center

位置：

Honors Announcement

Group News

Media Reports

Putting Hard Work First as We Embark on a New Journey: Tackling Tough Challenges, Achieving Breakthroughs, and Driving Innovation—Shijiazhuang Sihua Pharmaceutical Group Holds Spring Marketing Training and Awards Ceremony

Category:

Group News

发布时间：2025-02-05

【概要描述】 As the new year ushers in a fresh journey, we will forge ahead with renewed vigor and determination. On February 4, the 2025 Shijiazhuang Sihua Pharmaceutical Group New Year Marketing Training and Awards Ceremony was held in the Group’s R&D Center Auditorium. Attending the ceremony were Group leaders Su Xuejun, Wu Hengyao, Shi Jianhui, Meng Guo, Zhang Guozhen, Yu Zhou, Sun Lijie, Tian Pengmei, and other senior executives, along with all sales personnel from the Pharmaceutical Business Division and heads of relevant functional departments across the Group. The meeting was chaired by Qu Benyue, Executive President of the Group.

Putting Hard Work First as We Embark on a New Journey: Tackling Tough Challenges, Achieving Breakthroughs, and Driving Innovation—Shijiazhuang Sihua Pharmaceutical Group Holds Spring Marketing Training and Awards Ceremony

A new year ushers in a new journey, calling on us to forge ahead with renewed vigor. On February 4, the 2025 Shijiazhuang Sihua Pharmaceutical Group Spring Marketing Training and Awards Ceremony was held in the Group’s R&D Center Auditorium. Attending the ceremony were Group leaders Su Xuejun, Wu Hengyao, Shi Jianhui, Meng Guo, Zhang Guozhen, Yu Zhou, Sun Lijie, Tian Pengmei, and other senior executives, along with all sales personnel from the Pharmaceutical Business Division and heads of relevant functional departments across the Group. The meeting was chaired by Qu Benyue, Executive President of the Group.

At the awards ceremony, Zhang Guozhen, Group Executive President and General Manager of the Pharmaceutical Business Unit, stated in his opening remarks that the Group will comprehensively and thoroughly implement its “Grand Marketing” strategic vision, proactively align with policy guidance, seize market opportunities, and rigorously execute a differentiated and diversified marketing strategy. By enhancing business and service capabilities, the Group will boost marketing effectiveness, take the lead in operations, and strive to transform its innovation strengths into market and development advantages, thereby delivering new achievements and demonstrating renewed commitment to accelerating the Group’s innovative, high-quality development.

At the awards ceremony, Group leaders Su Xuejun, Wu Hengyao, Shi Jianhui, Meng Guo, Zhang Guozhen, Yu Zhou, Sun Lijie, and Tian Pengmei presented certificates and cash prizes to representatives of the teams and individuals who had been honored with the Business Excellence Award, Comprehensive Ranking Award, Market Development Award, and Key Product Sales Performance Award.

Representatives of the advanced collectives and individuals, An Siyao and Guo Hongda, delivered statements. They pledged to cherish this honor, remain true to their original aspiration, continue to strive with renewed vigor, tackle tough challenges with unwavering confidence and proactive action, and make further contributions to the high-quality achievement of the 2025 sales targets.

Su Xuejun, Chairman of the Group, fully commended the tremendous contributions made over the past year by the vast ranks of marketing professionals for their relentless drive, pioneering spirit, and unwavering pursuit of excellence in advancing the Group’s development. On behalf of the Group’s leadership team, he extended sincere greetings and best wishes to all marketing personnel working diligently on the front lines of the market and to their families, and offered heartfelt congratulations to the outstanding marketing teams and individuals who were recognized and honored.

Su Xuejun pointed out that the past year was an exceptionally extraordinary and unusual one. Under the strong leadership of Chairman Qu Jiguang of the Board of Directors, the Group has comprehensively and thoroughly implemented the new development philosophy, steadfastly pursued an innovation-driven strategy, and adhered to integrated development spanning both active pharmaceutical ingredients and finished dosage forms. As a result, a new phase of product iteration and development has been ushered in, the foundation for the company’s high-quality growth has grown ever stronger, and its innovative influence and market competitiveness have achieved a significant leap forward. The Group’s leading position in the industry in terms of the number of generic drugs that have passed evaluation and the number of APIs that have received approval has laid a solid product foundation and created ample room for future development, serving as the greatest source of confidence and driving force for accelerating the company’s growth.

Seizing the momentum of the “Great Marketing” initiative, we will press forward with a work-first approach and strive for breakthroughs and innovation. Su Xuejun emphasized that today’s conference is not only a summary and awards ceremony but also a rallying call to commit ourselves to victory. The bugle has sounded for the charge; the battleground for tackling tough challenges lies just ahead. In the face of a severe and complex business environment, all marketing departments must adopt the mindset that “the start is a decisive battle and the beginning is a sprint,” energize our spirit and bolster our confidence in development, stay focused on our core responsibilities and main businesses, break free from conventional thinking, go all out, continuously innovate our marketing strategies, enhance service quality, and strengthen compliant operations. We must rigorously control new customer acquisition, intensify market development, stabilize existing accounts, expand new business, and increase overall volume—working in unity and synergy, putting “work first” and striving with vigor. With a sense of urgency that brooks no delay, a sense of crisis that allows no complacency, and a sense of responsibility that compels us to act without hesitation, and armed with the tenacity and determination to “not return until Loulan is conquered,” we will make a full-scale push to achieve the 2025 goals and make new and even greater contributions as marketers to writing a new chapter of innovative, high-quality development for the Group.

Diligence brings spring early; now is the time to forge ahead with determination. The spirit of the conference has resonated strongly among marketing professionals. They have unanimously pledged to set higher standards for themselves, work tirelessly, confront challenges head-on, and embrace bold new initiatives—embracing the ethos of “If others do one, I will do ten; if others do ten, I will do a hundred”—to break through barriers, move forward with resolve, live up to their mission, and devote all their wisdom and energy to fully achieving the year’s business objectives.

On the day before the awards ceremony, the Group’s Pharmaceutical Business Unit convened a briefing on the 2025 target objectives, re-deploying, re-implementing, and re-mobilizing efforts to further ensure the successful fulfillment of the year’s tasks.

Subsequently, several departments within the Pharmaceutical Business Unit organized specialized training sessions. The Marketing Center of the Pharmaceutical Business Unit tailored in-house training programs to align with the specific business characteristics and priorities of each department. A series of innovative training courses—such as “Code of Conduct for Daily Sales Activities,” “Customer Acquisition and Retention,” and “Sharing of Best Practices in Precision Market Development and Water-Injectable Product Development”—proved highly beneficial to marketing professionals and managers from relevant functional departments.

“To serve as effective brand ambassadors for our products, sales personnel must have a solid understanding of new product knowledge—this is a crucial component of enhancing our sales capabilities. Our goal is to ensure that more customers are aware of the advantages of our Sihao Pharmaceutical products.” Following the completion of the training course, “Market Strategy and Key Advantages of YiruiChun® Fat Emulsion (10%)/Amino Acids (15%)/Glucose (20%) Injection,” sales staff from the Infusion Products Center remarked that the instructor’s presentation was highly practical, highly instructive, and deeply insightful, bolstering their confidence in successfully advancing future market development efforts.

“Over the past two years, the Group has steadily accelerated its R&D and innovation efforts, continuously optimized its product portfolio, and successfully translated numerous innovative breakthroughs into practical applications. Thanks to systematic training, we now have a much clearer understanding of the Group’s substantial growth advantages and untapped potential, which has been highly inspiring. Moving forward, we will adopt a forward-looking mindset, holistic planning, strategic positioning, and integrated execution in our market development initiatives, putting what we have learned in the training into practice and striving to convert our innovation strengths into tangible results in market expansion,” said the head of the New Drug Division of the Group’s Pharmaceutical Business Unit with full confidence.

Keywords:

Shijiazhuang Sihua Pharmaceutical Group: Bustling Post-Holiday Production Kick-Starts a Strong Start to the First Quarter

Shijiazhuang Sihua Pharmaceutical Group Holds a Symposium for Scientific and Technological Personnel to Welcome the New Year

Shijiazhuang Sihua Pharmaceutical Group: Bustling Post-Holiday Production Kick-Starts a Strong Start to the First Quarter

Shijiazhuang Sihua Pharmaceutical Group Holds a Symposium for Scientific and Technological Personnel to Welcome the New Year